Journal of ethnopharmacology · 2025
Dendrobium huoshanense attenuates Parkinsonian neurodegeneration via dual antioxidant and anti-inflammatory pathways.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yan Congjie, Liu Yingbo, Hong Suyu, Gu Zimeng, Li Qianye, Yuan Rong, Wang Yujuan, Tian Zeixi, Wang Weidong, Dai Jun, Liu Zenggen
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Dendrobium huoshanense (DH), a traditional Chinese medicinal herb, is traditionally used for its anti-inflammatory and antioxidant properties, suggesting potential against neurodegenerative diseases like Parkinson's disease (PD).
AIM OF THE STUDY: This study investigated how growth years affect DH's chemical composition and neuroprotective activities against PD, focusing on anti-inflammatory and antioxidant mechanisms.
METHODS: DH extracts from different growth years (N1-N4) were analyzed chemically. Their effects were evaluated in D-galactose-stimulated PC12 cells and LPS-activated BV-2 microglia. The most potent four-year-old DH was further tested in an MPTP-induced PD mouse model using behavioral tests, immunohistochemistry, and Western blotting.
RESULTS: Four-year-old DH exhibited the highest content of active compounds and significantly alleviated motor deficits in PD mice. It reduced oxidative stress and neuroinflammation by suppressing the NF-κB/NLRP3 pathway and activating the HO-1/Nrf2 antioxidant pathway.
CONCLUSION: DH exerts neuroprotective effects against PD through dual regulation of the HO-1/Nrf2 and NF-κB/NLRP3 pathways, with efficacy enhanced by longer growth periods. These findings support DH's potential as a therapeutic agent for PD.
AIM OF THE STUDY: This study investigated how growth years affect DH's chemical composition and neuroprotective activities against PD, focusing on anti-inflammatory and antioxidant mechanisms.
METHODS: DH extracts from different growth years (N1-N4) were analyzed chemically. Their effects were evaluated in D-galactose-stimulated PC12 cells and LPS-activated BV-2 microglia. The most potent four-year-old DH was further tested in an MPTP-induced PD mouse model using behavioral tests, immunohistochemistry, and Western blotting.
RESULTS: Four-year-old DH exhibited the highest content of active compounds and significantly alleviated motor deficits in PD mice. It reduced oxidative stress and neuroinflammation by suppressing the NF-κB/NLRP3 pathway and activating the HO-1/Nrf2 antioxidant pathway.
CONCLUSION: DH exerts neuroprotective effects against PD through dual regulation of the HO-1/Nrf2 and NF-κB/NLRP3 pathways, with efficacy enhanced by longer growth periods. These findings support DH's potential as a therapeutic agent for PD.
Предметные рубрики MeSH
AnimalsDendrobiumPC12 CellsAntioxidantsAnti-Inflammatory AgentsMiceNeuroprotective AgentsMaleRatsNF-kappa BOxidative StressMice, Inbred C57BLPlant ExtractsNF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinDisease Models, AnimalMicrogliaHeme Oxygenase-1Signal TransductionMembrane Proteins